sur Secarna Pharmaceuticals GmbH & Co. KG
Secarna Pharmaceuticals Appoints New CEO Konstantin Petropoulos
Secarna Pharmaceuticals has announced the promotion of Konstantin Petropoulos to Chief Executive Officer. Previously serving as Chief Business Officer since June 2023, Petropoulos succeeds Alexander Gebauer, who will focus on his company Galimedix Therapeutics. Gebauer will remain as an advisor to ensure a smooth leadership transition.
Petropoulos expressed excitement about his new role, highlighting Secarna's advancements in oligonucleotide technology, aimed at addressing untreatable conditions. Gebauer praised Petropoulos' successful business efforts and expressed confidence in his ability to continue expanding Secarna's pipeline and partnerships.
With a background in oncology research and business management, Petropoulos brings extensive industry experience from roles at AMW GmbH, Leukocare AG, and Bayer AG. His strategic expertise includes developing key business agreements and alliances.
R. E.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Secarna Pharmaceuticals GmbH & Co. KG